Search Results - "Kale, Vishakha"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal Transdifferentiation: In Vitro Analysis

    Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal Transdifferentiation: In Vitro Analysis by Frid, Maria G, Kale, Vishakha A, Stenmark, Kurt R

    Published in Circulation research (14-06-2002)
    “…Though in the past believed to be a rare phenomenon, endothelial-mesenchymal transdifferentiation has been described with increasing frequency in recent years…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Yin and Yang of an endothelial cell: from normal to the extreme in growth, secretion, and transdifferentiation capabilities

    Yin and Yang of an endothelial cell: from normal to the extreme in growth, secretion, and transdifferentiation capabilities by Frid, Maria G., Aldashev, Almaz A., Crossno, Joe T., Jorgensen, Jennifer M., Kale, Vishakha A., Stenmark, Kurt R.

    Published in Paediatric Respiratory Reviews (2004)
    Get full text
    Book Review Journal Article
    Save to List
    Saved in:
  3. 3
    The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes

    The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes by Melchert, Magda, Kale, Vishakha, List, Alan

    Published in Current opinion in hematology (01-03-2007)
    “…PURPOSE OF REVIEWThe aim of this article is to discuss the relevant pathobiologic effects of lenalidomide and the most recent clinical evidence to support its…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Phase II Pilot Study of Oral Dasatinib in Subjects with Higher Risk Myelodysplastic Syndrome (MDS) Who Failed Conventional Therapy

    Phase II Pilot Study of Oral Dasatinib in Subjects with Higher Risk Myelodysplastic Syndrome (MDS) Who Failed Conventional Therapy by Duong, Vu H., Jaglal, Michael V., Zhang, Ling, Kale, Vishakha, Lancet, Jeffrey E., Komrokji, Rami S., List, Alan F.

    Published in Blood (18-11-2011)
    “…Abstract 1727 Src family kinases (SFKs), in particular Lyn kinase, play a critical role in mediating GM-CSF and G-CSF response in myeloid leukemic cell…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy

    Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy by Duong, Vu H, Jaglal, Michael V, Zhang, Ling, Kale, Vishakha, Lancet, Jeffrey E, Komrokji, Rami S, List, Alan F

    Published in Leukemia research (01-03-2013)
    “…Abstract Given evidence for the role of Src family kinases, especially Lyn kinase, in myeloblast proliferation and the in vitro inhibitory activity of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Immunomodulatory drugs (IMiDs): a new treatment option for myelodysplastic syndromes

    Immunomodulatory drugs (IMiDs): a new treatment option for myelodysplastic syndromes by Kale, Vishakha, List, Alan F

    Published in Current pharmaceutical biotechnology (01-10-2006)
    “…The IMiDs represent a new proprietary class of thalidomide analogues that possess greater potency and less toxicity than the parent compound. As a group, these…”
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: